Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
CONTEXT: Despite quality assurance standards, Papanicolaou (Pap) test characteristics remain less than optimal. OBJECTIVE: To compare the societal costs and benefits of human papillomavirus (HPV) testing, Pap testing, and their combination to screen for cervical cancer. DESIGN, SETTING, AND POPULATION: A simulation model of neoplasia natural history was used to estimate the societal costs and quality-adjusted life expectancy associated with 18 different general population screening strategies: Pap plus HPV testing, Pap testing alone, and HPV testing alone every 2 or 3 years among hypothetical longitudinal cohorts of US women beginning at age 20 years and continuing to 65 years, 75 years, or death. MAIN OUTCOME MEASURE: Discounted costs per quality-adjusted life-year (QALY) saved of each screening strategy. RESULTS: Maximal savings in lives were achieved by screening every 2 years until death with combined HPV and Pap testing at an incremental cost of $76 183 per QALY compared with Pap testing alone every 2 years. Stopping biennial screening with HPV and Pap testing at age 75 years captures 97.8% of the benefits of lifetime screening at a cost of $70 347 per QALY. Combined biennial HPV and Pap testing to age 65 years captures 86.6% of the benefits achievable by continuing to screen until age 75 years. Human papillomavirus screening alone was equally effective as Pap testing alone at any given screening interval or age of screening cessation but was more costly and therefore was dominated. In sensitivity analyses, HPV testing would be more effective and less costly than Pap testing at a cost threshold of $5 for an HPV test. CONCLUSIONS: Screening with HPV plus Pap tests every 2 years appears to save additional years of life at reasonable costs compared with Pap testing alone. Applying age limits to screening is a viable option to maintain benefits while reducing costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., & Insalaco, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,658
Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401501 · Cited by 2,299
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., Walker, J. L., & Gersell, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401503 · Cited by 1,923
Moses, L. E., Shapiro, D., & Littenberg, B. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121403 · Cited by 1,405
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,210
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Nanda, K., McCrory, D. C., Myers, E. R., Bastian, L. A., Hasselblad, V., Hickey, J. D., & Matchar, D. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00009 · Cited by 1,089
Stoler, M. H. (2001) · JAMA · doi:10.1001/jama.285.11.1500 · Cited by 1,087
Solomon, D., Schiffman, M., & Tarone, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 975
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957 · cited 1×
“Laboratory fee Hybrid Capture II 30 (12-80)”
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Frisch, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1500 · Cited by 885
Probabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860 · cited 1×
“Laboratory fee Hybrid Capture II 30 (12-80)”
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 837
Nobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 684
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Natural History of Dysplasia of the Uterine Cervix
Holowaty, P., Miller, A. B., Rohan, T., & To, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.252 · Cited by 608
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Schiffman, M., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M. D., et al. (2000) · JAMA · doi:10.1001/jama.283.1.87 · Cited by 540
Interim Guidelines for Management of Abnormal Cervical Cytology
Kurman, R. J. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470070037 · Cited by 530
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470 · cited 1×
“HSIL: hysterectomy or cone biopsy 98 (90-99)”
Wright, Jr. (2000) · JAMA · doi:10.1001/jama.283.1.81 · Cited by 468
Cox, J. T., Lorincz, A. T., Schiffman, M. H., Sherman, M. E., Cullen, A., & Kurman, R. J. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90026-8 · Cited by 417
Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M., & Kenemans, P. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610305 · Cited by 368
Gold, M. R., Franks, P., McCoy, K. I., & Fryback, D. G. (1998) · Medical Care · doi:10.1097/00005650-199806000-00002 · Cited by 357
Socioeconomic Factors and Cancer Incidence Among Blacks and Whites
Baquet, C. R., Horm, J. W., Gibbs, T., & Greenwald, P. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.8.551 · Cited by 334
Human papillomavirus testing in primary cervical screening
Cuzick, J., Szarewski, A., Terry, G., Hanby, A., Maddox, P., Anderson, M., Steele, S. J., Guillebaud, J., & Kocjean, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91086-7 · Cited by 328
Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., & Manos, M. M. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.997 · Cited by 320
Behavior of mild cervical dysplasia during long‐term follow‐up
Nasiell, K., Roger, V, & Nasiell, M. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90258-x · Cited by 312
Melkert, P. W. J., van den Brule, A. J. C., Risse, E. K. J., van Diest, P. J., Meijer, C. J. L. M., Walboomers, J. M. M., Helmerhorst, T., Hopman, E., Bleker, O. P., & Schipper, M. E. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530609 · Cited by 281
HPV testing in primary screening of older women
Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W.-K., Krausz, T., & Soutter, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690730 · Cited by 268
Human papillomavirus and invasive cervical cancer in Brazil
Eluf-Neto, J., Booth, M., Muñoz, N., Bosch, F., Meijer, C., & Walboomers, J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.18 · Cited by 268
Sellors, J. W., Lorincz, A. T., Mahony, J. B., Mielzynska, I., Lytwyn, A., Roth, P., Howard, M., Chong, S., Daya, D., Chapman, W. B., et al. (2000) · Europe PMC (PubMed Central) · Cited by 256
Blackman, D., Bennett, E., & Miller, D. S. (1999) · PubMed · Cited by 250
Rozendaal, L., Walboomers, J. M. M., van der Linden, J. C., Voorhorst, F. J., Kenemans, P., Helmerhosrt, T. J. M., van Ballegooijen, M., & Meijer, C. J. L. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961211)68:6<766::aid-ijc13>3.0.co;2-z · Cited by 244
Liaw, K.-L., Glass, A. G., Manos, M. M., Greer, C. E., Scott, D. R., Sherman, M., Burk, R. D., Kurman, R. J., Wacholder, S., Rush, B. B., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.954 · Cited by 242
Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam, S., Franco, E. L., & Ferenczy, A. S. (2000) · PubMed · Cited by 240
Determinants of Genital Human Papillomavirus Infection in Low-Risk Women in Portland, Oregon
BAUER, H. M., HILDESHEIM, A., SCHIFFMAN, M. H., GLASS, A. G., RUSH, B. B., SCOTT, D. R., CADELL, D. M., KURMAN, R. J., & MANOS, M. M. (1993) · Sexually Transmitted Diseases · doi:10.1097/00007435-199309000-00007 · Cited by 233
Follen Mitchell, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00246-4 · Cited by 231
BURK, R. D., KELLY, P., FELDMAN, J., BROMBERG, J., VERMUND, S. H., DEHOVITZ, J. A., & LANDESMAN, S. H. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199607000-00013 · Cited by 227
Londesborough, P., Ho, L., Terry, G., Cuzick, J. M., Wheeler, C. M., & Singer, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961021)69:5<364::aid-ijc2>3.3.co;2-u · Cited by 224
Schneider, A., Hoyer, H., Lotz, B., Leistritza, S., Kühne-Heid, R., Nindl, I., Müller, B., Haerting, J., & Dürst, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<529::aid-ijc11>3.0.co;2-g · Cited by 222
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
Kuhn, L., Denny, L., Pollack, A., Lorincz, A., Richart, R. M., & Wright, T. C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.818 · Cited by 217
Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries
Mandelblatt, J. S., Lawrence, W. F., Gaffikin, L., Limpahayom, K. K., Lumbiganon, P., Warakamin, S., King, J., Yi, B., Ringers, P., & Blumenthal, P. D. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1469 · Cited by 212
Self-citationPeyton, C. L., Schiffman, M., Lörincz, A. T., Hunt, W. C., Mielzynska, I., Bratti, C., Eaton, S., Hildesheim, A., Morera, L. A., Rodriguez, A. C., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.11.3248-3254.1998 · Cited by 210
Sherman, M. E., Schiffman, M. H., Lorincz, A. T., Michele Manos, M., Scott, D. R., Kurman, R. J., Kiviat, N. B., Stoler, M., Glass, A. G., & Rush, B. B. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.2.182 · Cited by 204
Herrero, R., Schiffman, M. H., Bratti, C., Hildesheim, A., Balmaceda, I., Sherman, M. E., Greenberg, M., Cárdenas, F., Gómez, V., Helgesen, K., et al. (1997) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49891997000500005 · Cited by 204
Cuzick, Sasieni, Davies, Adams, Normand, Frater, van Ballegooijen, & van den Akker (1999) · Health Technology Assessment · doi:10.3310/hta3140 · Cited by 204
Evaluation of cervical cytology.
McCrory, D., Matchar, D. B., Bastian, L., Datta, S., Hasselblad, V., Hickey, J., Myers, E. R., & Nanda, K. (1999) · PubMed Central · Cited by 196
Bureau of Labor Statistics Web Site
D'Esposito, J. E. (2000) · Journal of Government Information · doi:10.1016/s1352-0237(00)00164-7 · Cited by 181
Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer
van Oortmarssen, G., & Habbema, J. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.350 · Cited by 178
Determinants of Genital Human Papillomavirus Infection in Low-Income Women in Washington, D.C
HILDESHEIM, A., GRAVITT, P., SCHIFFMAN, M. H., KURMAN, R. J., BARNES, W., JONES, S., TCHABO, J.-G., - BRINTON, L. A., COPELAND, C., EPP, J., et al. (1993) · Sexually Transmitted Diseases · doi:10.1097/00007435-199309000-00008 · Cited by 164
Cuzick, J. M., Sasieni, P. D., Davies, P. O., Adams, J., Normand, C. E. M., Frater, A. P., van Ballegooijen, M., & Marle, M. E. V. D. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1375 · Cited by 155
Syrjänen, K. J., Kataja, V. V., Yliskoski, M. H., Chang, F., Syrjänen, K. J., & Saarikoski, S. (1992) · PubMed · Cited by 152
Lörincz, A. T. (1996) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.1996.tb01081.x · Cited by 149
Cost Effectiveness of Cervical Cancer Screening for the Elderly
Fahs, M. C., Mandelblatt, J., Schechter, C., & Muller, C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-520 · Cited by 138
Self-citationAccuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture
SCHIFFMAN, M. H., Kiviat, N. B., Burk, R. D., Shah, K. V., Daniel, R. W., Lewis, R., Kuypers, J. M., Manos, M. M., Scott, D. R., & Sherman, M. E. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.545-550.1995 · Cited by 135
Cost-effectiveness of 3 Methods to Enhance the Sensitivity of Papanicolaou Testing
Brown, A. D., & Garber, A. M. (1999) · JAMA · doi:10.1001/jama.281.4.347 · Cited by 124
A cohort study of cervical cancer screening in British Columbia.
Boyes, D. A., Morrison, B., Knox, E. G., Draper, G. J., & Miller, A. B. (1982) · PubMed · Cited by 120
Is HIV infection a cofactor for cervical squamous cell neoplasia?
Mandelblatt, J. S., Kanetsky, P. A., Eggert, L., & Gold, K. F. (1999) · PubMed · Cited by 117
Self-citationComputer-assisted cervical cancer screening using neural networks
Mango, L. J. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90098-1 · Cited by 110
Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young Women
MOSCICKI, A.-B., PALEFSKY, J., SMITH, G., SIBOSHSKI, S., & SCHOOLNIK, G. (1993) · Obstetrics & Gynecology · doi:10.1097/00006250-199310000-00021 · Cited by 108
Reid, R., Greenberg, M., Lörincz, A. T., Jenson, A. B., Laverty, C. R. A., Husain, M., Daoud, Y., Zado, B., White, T., Cantor, D., et al. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)91425-v · Cited by 108
Goldie, S. J., Weinstein, M. C., Kuntz, K. M., & Freedberg, K. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-2-199901190-00003 · Cited by 105
Assessing the effectiveness of health interventions for cost-effectiveness analysis
Mandelblatt, J. S., Fryback, D. G., Weinstein, M. C., Russell, L. B., & Gold, M. R. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.07107.x · Cited by 104
Self-citationNatural history of cervical neoplasia: Overview and update
Kiviat, N. B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70011-x · Cited by 101
Serwadda, D., Wawer, M. J., Shah, K. V., Sewankambo, N. K., Daniel, R., Li, C., Lorincz, A., Meehan, M. P., Wabwire‐Mangen, F., & Gray, R. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315026 · Cited by 101
Fine-needle aspiration of the adult kidney
Renshaw, A. A., Granter, S. R., & Cibas, E. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970425)81:2<89::aid-cncr2>3.0.co;2-9 · Cited by 96
Meijer, C. J. L. M., van den Brule, A. J. C., Snijders, P. J. F., Helmerhorst, T. J. M., Kenemans, P., & Walboomers, J. M. M. (1992) · PubMed · Cited by 95
MYERS, E. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00979-0 · Cited by 92
Sawaya, G. F., Grady, D., Kerlikowske, K. M., Valleur, J. L., Barnabei, V. M., Bass, K. M., Snyder, T. E., Pickar, J. H., Agarwal, S. K., & Js, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00009 · Cited by 90
Schneider, A., Zahm, D. M., Kirchmayr, R., & Schneider, V. L. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70602-6 · Cited by 89
Riethmuller, D., Gay, C., Bertrand, X., Bettinger, D., Schaal, J. P., Carbillet, J. P., Lassabe, C., Arveux, P., Seilles, E., & Mougin, C. (1999) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199909000-00009 · Cited by 86
Adam, E., Berkova, Z., Daxnerová, Z., Icenogle, J. P., Reeves, W. C., & Kaufman, R. H. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70208-0 · Cited by 84
Short-term fluctuations in the detection of cervical human papillomavirus DNA
WHEELER, C., GREER, C., BECKER, T., HUNT, W., ANDERSON, S., & MICHELEMANOS, M. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00120-2 · Cited by 84
The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data
Eddy, D. M. (1987) · Cancer · doi:10.1002/1097-0142(19870901)60:5<1117::aid-cncr2820600533>3.0.co;2-h · Cited by 83
van Ballegooijen, M., van den Akker-van Marle, M., Warmerdam, P., Meijer, C., Walboomers, J., & Habbema, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.440 · Cited by 80
Gaarenstroom, K. N., Melkert, P., Walboomers, J. M. M., van den Brule, A. J. C., van Bommel, P. F. J., Meyer, C. J. L. M., Voorhorst, F. J., Kenemans, P., & Helmerhorst, T. J. M. (1994) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.1994.04020073.x · Cited by 77
Molecular methods for the detection of human papillomavirus infection.
Lörincz, A. T. (1996) · PubMed · Cited by 75
Walboomers, J. M. M., Husman, A. D. R., Snijders, P. J. F., Stel, H. V., Risse, E. K. J., Helmerhorst, T. J. M., Voorhorst, F. J., & Meijer, C. J. L. M. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.8.728 · Cited by 75
Cervical‐cancer screening: Attendance and cost‐effectiveness
Koopmanschap, M. A., van Oortmarssen, G. J., van Agt, H. M. A., van Ballegooijen, M., Habbema, J. D. F., & Lubbe, K. T. N. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450305 · Cited by 74
Can papilloma virus testing be used to improve cervical cancer screening?
Jenkins, D., Sherlaw-Johnson, C., & Gallivan, S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6<768::aid-ijc10>3.0.co;2-0 · Cited by 71
Determinants of Persistent Detection of Human Papillomavirus DNA in the Uterine Cervix
Brisson, J., Bairati, I., Morin, C., Fortier, M. A., Bouchard, C., Christen, A., Bernard, P., Roy, M., & Meisels, A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.4.794 · Cited by 68
Prospective follow-up of genital HPV infections: Survival analysis of the HPV typing data
Kataja, V. V., Syrj�nen, K. J., Syrjänen, K. J., MÄNTYJÄRVI, R. A., Yliskoski, M. H., Saarikoski, S., & Salonen, J. T. (1990) · European Journal of Epidemiology · doi:10.1007/bf00155542 · Cited by 57
Nelson, J. H., Averette, H. E., & Richart, R. M. (1989) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.39.3.157 · Cited by 49
Evaluating cervical cancer screening programmes for developing countries
Sherlaw‐Johnson, C., Gallivan, S., & Jenkins, D. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970717)72:2<210::aid-ijc2>3.0.co;2-u · Cited by 48
Cost-Effectiveness of Rescreening Conventionally Prepared Cervical Smears by PAPNET Testing
Schechter, C. B. (1996) · Acta Cytologica · doi:10.1159/000334021 · Cited by 42
Helms, L. J., & Melnikow, J. A. (1999) · Medical Care · doi:10.1097/00005650-199907000-00005 · Cited by 42
Patterns of care for invasive cervical cancer. Results of a national survey of 1984 and 1990
Jones, W. B., Shingleton, H. M., Russell, A. H., Chmiel, J. S., Fremgen, A. M., Clive, R. E., Zuber-Ocwieja, K. E., & Winchester, D. P. (1995) · Cancer · doi:10.1002/1097-0142(19951115)76:10+<1934::aid-cncr2820761310>3.0.co;2-8 · Cited by 39
Costa, S., Sideri, M. G., Syrjänen, K. J., Terzano, P., Nuzzo, M. D., Simone, P. D., Cristiani, P., Finarelli, A. C., Bovicelli, A., Zamparelli, A., et al. (2000) · Acta Cytologica · doi:10.1159/000328471 · Cited by 29
Shah, K. V., Kessis, T. D., Shah, F., Gupta, J. W., Shibata, D. K., & Jones, R. W. (1996) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199604000-00006 · Cited by 26
Diagnosing human papillomaviruses: recent advances
Jenkins, D. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200102000-00010 · Cited by 26
Bosch, F. X., de Sanjosé, S., & Muñóz, N. (1994) · PubMed · Cited by 24
Smith, E., Johnson, S. R., Figuerres, E. J., Mendoza, M., Fedderson, D., Haugen, T. H., & Turek, L. P. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4703 · Cited by 24
Gjøen, K., Olsen, A. O., Magnus, P. M., Grinde, B., Sauer, T., & Ørstavik, I. (1996) · Apmis · doi:10.1111/j.1699-0463.1996.tb00688.x · Cited by 22
Svare, E. I., Kjær, S. K., Smits, H. L., Poll, P., Tjong‐A‐Hung, S. P., & ter Schegget, J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00131-2 · Cited by 19
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
“The computer models showed that a biennial or triennial cervical cancer screening program involving liquid-based cytology and reflex HPV DNA testing is more effective and less costly than annual screening by conventional cytology for women with ASC (57, 74).”
InfluentialAmerican Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Cytology versus HPV testing for cervical cancer screening in the general population
Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008587.pub2 · Cited by 494
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
Kulasingam, S. L. (2003) · JAMA · doi:10.1001/jama.290.6.781 · Cited by 337
Metadata
- Authors
- Mandelblatt, J. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-05-08
- Volume
- 287
- Issue
- 18
- Pages
- 2372
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1992161500
- Cited by
- 308
- References
- 101
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.